Predict your next investment

NuMedii company logo
HEALTHCARE | Drug Development
numedii.com

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$3.5M

Last Raised

$3.5M | 8 yrs ago

About NuMedii

NuMedii discovers and de-risks effective new drugs by translating its predictive Big Data technology into therapies with a higher probability of therapeutic success. The company's Big Data technology consists of billions of data points of ever-increasing amounts of comprehensive disease, pharmacological and clinical data. NuMedii integrates these data with network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The company has successfully validated its Big Data technology as six of six drug candidates have demonstrated preclinical activity for the predicted new indication. NuMedii will partner with pharmaceutical companies for the development and commercialization of its therapeutic candidates.

NuMedii Headquarter Location

PO Box 7381

Menlo Park, California, 94026,

United States

650-918-6363

Latest NuMedii News

Global AI for Drug Discovery Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025: Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics

Mar 11, 2021

Thursday, 11 Mar 2021 05:19 pm Global AI for Drug Discovery Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025: Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity. By SMN Bureau   Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity. A Latest report published by The Insight Partners named “ AI for Drug Discovery Market ” presents currents and future opportunities, growth scenario, market share and AI for Drug Discovery industry size. The AI for Drug Discovery Report is an excellent source that provides present as well as future analysis of the Industry (both technical & financial) in detail. In addition, the competitive analysis provided in the report gives a superficial idea about the key strategies used by the key players in the market which help them grown their market status. This research study has considered key break downs in the Industry and competing factors which is valuable to take your business to the innovative level. Get Free Sample Brochure (including full TOC, Tables and Figures: https://www.theinsightpartners.com/sample/TIPRE00004177/?source=smartmarketnews-10408 This report can be customized based on the client-specific requirements and stated development. The AI for Drug Discovery Market awareness and growth status are reflected in the report. In-depth insights into the emerging market manufacturers, a SWOT analysis will improve the forecast market growth for profitable business ideas. The AI for Drug Discovery Industry overview, recent developments, manufacturing base, consumption details are scrutinized deeply. Competitive Landscape of Global AI for Drug Discovery Market: Atomwise, Inc. Global AI for Drug Discovery Market Segmentation and Regional Analysis: The AI for Drug Discovery Market share for each type and application is for the year 2020. The revenue share, sales price, upstream raw material suppliers, downstream buyers, and pricing array of AI for Drug Discovery Market is instructed. The dynamic changes in AI for Drug Discovery Industry, technological advancements, mergers & acquisitions are stated. The complete AI for Drug Discovery business profile, products & services overview, geographical presence, import-export details and Market share, gross margin, etc. is summarized in this study. Note: If you have any special requirements, please let us know and we will offer you the report as you want. Global AI for Drug Discovery Market Segment By Region: North America (United States, Canada, Mexico, Europe, Germany, UK, France, Italy, Spain, Russia, Others) Asia-Pacific (China, Japan, South Korea, Australia, India, Southeast Asia, Others) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Others) South America (Brazil, Argentina, Columbia, Chile, Others) AI for Drug Discovery report can be divided into following 12 segments Segment 1, states the objectives of AI for Drug Discovery market, review, introduction, product description, growth aspects, and industry presence; Segment 2, elaborates the AI for Drug Discovery market based on key players, their market share, sales volume, company profiles, AI for Drug Discovery competitive market scenario and pricing structure from 2015 to 2019; Segment 3, analyzes the AI for Drug Discovery market at a regional level based on sales ratio and market size from 2015 to 2019; Segment 4, 5, 6 and 7, explains the AI for Drug Discovery market at the country level based on product type, applications, revenue analysis; Segment 8 and 9, states the AI for Drug Discovery industry overview during past, present and forecast period from 2020 to 2026; Segment 10 and 11, describes the market status, plans, expected growth based on regions, type and application in detail for a forecast period of 2020-2026; Segment 12, covers the marketing channels, dealers, manufacturers, trader, distributors, consumers of AI for Drug Discovery. About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense. Contact Us: Email: sales@theinsightpartners.com

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NuMedii

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NuMedii is included in 6 Expert Collections, including Smart Money VCs (2017-2019).

S

Smart Money VCs (2017-2019)

6,297 items

We crunched the data to identify the 24 VC firms with the best combination of portfolio valuations and investment outcomes.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

A

Artificial Intelligence ( AI ) in Healthcare

826 items

These healthcare startups are using AI to discover new drugs, remotely monitor patients, securely transfer patient data, and more.

C

Clinical Trials Tech

311 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

F

Future of Pharma R&D

62 items

b

big data

1,068 items

NuMedii Patents

NuMedii has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/4/2014

Beta blockers, Inflammations, Gastrointestinal tract disorders, Amines, Autoimmune diseases

Application

Application Date

4/4/2014

Grant Date

Title

Related Topics

Beta blockers, Inflammations, Gastrointestinal tract disorders, Amines, Autoimmune diseases

Status

Application

NuMedii Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NuMedii Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.